Press release
Pharyngitis Market Future Forecast Indicates Impressive Growth Rate
Pharyngitis also known as pharynx is inflammation of the back of the throat resulting in a sore throat. It may be bacterial or viral, the most common bacteria that infect human throat is Group A Streptococcus. Various market players are working on developing rapid diagnostic testing solutions for the fast detection of infection to provide treatment at an early stage. According to the medical professionals, around 50% of a sore throat or pharyngitis is caused by viral infection, while around 15-20% is caused by bacterial infection. Hence, throat lozenges are also being prescribed for people suffering from pharyngitis and it also offers temporary relief from cough and cold, which the most common cause of sore throat. As per Randomized Controlled Trial (RCT) published recently in Canadian Medical Association Journal, found that probiotics and xylitol chewing gum have no effect on a sore throat or pharyngitis symptoms. Hence, drug manufacturers are conducting research to develop new drugs to fight sore throat without causing any side-effects.Request a report sample to gain comprehensive market insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=361
As per the report compiled by Fact.MR, the global pharyngitis market is expected to witness sluggish growth. The market is likely to register 3.4% CAGR during the forecast period 2017-2026. The global pharyngitis market is also estimated to reach US$ 1,679.0 million revenue by the end of 2026. Pharyngitis is the most common problem among people. It is mostly caused due to other illness such as flu, cold, or mononucleosis it results in sore throat. Most of the health providers diagnose pharyngitis with the help of rapid strep test. Medicines are given by doctor only after determining whether the infection is viral or bacterial. Hence, manufacturers of drugs are conducting research to develop more effective drugs to treat pharyngitis. Below are few insights on how the global pharyngitis market will perform in the coming years.
For information on the Research Approach used in the Report, Request Methodology@ https://www.factmr.com/connectus/sample?flag=RM&rep_id=361
5 Forecast Highlights on Global Pharyngitis Market
• Asia Pacific Excluding Japan (APEJ) is expected to remain dominant in the global pharyngitis market during the forecast period. Group A Streptococcus is a most common disease caused in settings of poverty, where transmission of an organism is possible due to the poor living condition. Hence, APEJ presents an opportunity for drug manufacturers. Moreover, the presence of key drug manufacturers in the region is also resulting in the growth of the market.
• North America is also expected to witness growth in the coming years. As the cigarette smoking is very common among young adults and is significantly associated with sore throat. Moreover, there has been an increase in the cases of acute pharyngitis diagnosed in children in the U.S.
• Beta lactams is expected to be one of the highly preferred drug class in the global pharyngitis market. By the end of 2026, beta lactams is estimated to reach close to US$ 500 million revenue.
• Retail pharmacies and drug stores are expected to witness the highest growth during the forecast period 2017-2026. Retail pharmacies and drug stores are estimated to exceed US$ 600 million revenue towards the end of 2026.
• Oral drug delivery is expected to be the most preferred drug administration route as it is convenient and also costs the least. Accounting for more than half of the revenue share, oral drug delivery is estimated to exceed US$ 1,200 million revenue by the end of 2026.
Get Full Access of the Report @ https://www.factmr.com/checkout/361/S
The report has also profiled leading players in the global market for pharyngitis, which will remain active through 2026. These include companies such as GlaxoSmithKline PLC, Pfizer Inc., Novartis AG, Zambon Group SpA, and BioStar Pharmaceuticals, Inc.
Unit No: AU-01-H
Gold Tower (AU)
Plot No: JLT-PH1-I3A
Jumeirah Lakes Towers, Dubai
United Arab Emirates
Contact: +353-1-6111-593
E-mail: sales@factmr.com
Website : https://www.factmr.com
About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports.
We believe transformative intelligence can educate and inspire businesses to make smarter decisions.
We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharyngitis Market Future Forecast Indicates Impressive Growth Rate here
News-ID: 2229438 • Views: …
More Releases from Fact.MR

Kenaf Seed Oil Market is Valued at USD 465.8 Million in 2025 | Prominent players …
The global Kenaf Seed Oil Market is experiencing a transformative growth phase, propelled by rising demand for natural, plant-based oils and expanding industrial adoption. According to the latest research from Fact.MR's Kenaf Seed Oil Market report, the market is projected to grow from an estimated USD 465.8 million in 2025 to USD 842.1 million by 2035, at a compound annual growth rate (CAGR) of 6.1 % over the forecast period.…

Functional Dairy Ingredients Market is Growing at a CAGR of 6.5% by 2035 | Angel …
The global Functional Dairy Ingredients Market is set to undergo robust expansion in the coming decade, according to Fact.MR's latest analysis. Valued at approximately USD 201.47 billion in 2022, the market is forecast to more than double to USD 417.16 billion by 2032, at a compound annual growth rate (CAGR) of 7.5% over the period. Rising consumer awareness of health, increasing demand for functional foods, and growing use of fortified…

Energy Drinks Market Charges Ahead: Surging to $169.5 Billion by 2035 on Functio …
The global energy drinks market is electrifying, set to surge from $87.8 billion in 2025 to a powerhouse $169.5 billion by 2035, driven by a dynamic compound annual growth rate (CAGR) of 6.8%. As fitness enthusiasts, gamers, and urban professionals demand quick, clean boosts that blend performance with wellness, leading manufacturers are turbocharging portfolios with natural, sugar-free formulations and e-commerce dominance. Urbanization, e-commerce proliferation, and a fitness boom are supercharging…

Global Citrus Essential Oil Market Set for Strong Growth Driven by Natural Produ …
According to a recent report by Fact.MR, the global citrus essential oil market is poised for remarkable growth, projected to reach USD 1.8 billion in 2025 and expand further to USD 3.2 billion by 2035, registering a steady compound annual growth rate (CAGR) of 5.9% during the forecast period. The report highlights that rising consumer preference for natural, plant-derived ingredients and the growing use of essential oils in food, cosmetics,…
More Releases for Pharyngitis
Increasing Strep Throat Transmission Fueling Growth In The Pharyngitis Treatment …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
What Is the Expected CAGR for the Pharyngitis Treatment Market Through 2025?
The market for pharyngitis treatment has seen consistent growth over the past few years. The predicted expansion is from $2.27 billion in 2024 to $2.37 billion in 2025, with a compound annual growth rate (CAGR) of 4.5%.…
Increasing Strep Throat Transmission Fueling Growth In The Pharyngitis Treatment …
The Pharyngitis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Pharyngitis Treatment Market Size and Projected Growth Rate?
In recent times, there has been a consistent increase in the size of the pharyngitis treatment market. It is projected to expand from $2.27…
Revolutionizing Relief: Contemporary Approaches to Pharyngitis Treatment
Pharyngitis is a disorder that is typically characterized by the inflammation of the pharynx. It is most commonly known as sore throat. It causes pain, discomfort and scratchiness in the throat that further leads to difficulty in swallowing. The most common cause of its occurrence is due to viral infections such as common cold, influenza and others. The early treatment is essential to relive the pain. The typical symptoms includes…
Pharyngitis Therapeutics Market - Regional Insights
Pharyngitis treatment is majorly based on the symptoms, depending the cause of pharyngitis for example, bacterial, fungal, and herpes simplex infections. The common symptoms of pharyngitis include sneezing, runny nose, headache, cough, fatigue, body aches, chills, and fever. Additionally, strep throat condition also occurs, which may lead to difficulty in swallowing, loss of appetite, nausea, fever, loss of taste, and swollen lymph nodes. Pain medication such as NSAIDs and…
Researchers Discover Potential of Pharyngitis Therapeutics Market
Pharyngitis Therapeutics Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Pharyngitis Therapeutics Market research report is a professional and in-depth study on the current state of Pharyngitis Therapeutics Industry.
The Pharyngitis Therapeutics Market research report covers the present scenario and the growth prospects of…
Pharyngitis Therapeutics Market - Regional Insights
Pharyngitis Therapeutics Market Dynamics
According to the study published in 2016, by the Centers for Disease Control and Prevention (CDC) and Pew Charitable Trusts, doctors are often prescribing the wrong antibiotics, which concluded that only 52% of the 44 million antibiotic prescribed for sinus infections, middle ear infections, and pharyngitis are the first-line drugs. Furthermore, in 2017, the World Health Organization (WHO) released a report suggesting that there is a serious…